Evaluation of Safety and Efficacy of Keratin Hair Therapy
NCT ID: NCT04489576
Last Updated: 2021-01-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
30 participants
INTERVENTIONAL
2020-11-15
2021-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the Efficacy of a New Supplement for Hair and Nails - in Vitro, Clinical, Subjective and Instrumental Study
NCT05945979
Study Evaluating the Effects of Dietary Supplement on Hair Thickness and Hair Strength in Individuals with Self-Perceived Thinning Hair
NCT06605768
Radiofrequency in Female Pattern Hair Loss
NCT05409755
Keratinocyte Growth Factor- Hair Serum for the Prevention of Chemotherapy Induced Alopecia
NCT04554732
Comparison Between Platelet Rich Plasma and Nanofat as an Adjuvant Therapy in HairTransplantation
NCT07287579
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group (1): Treatment with keratin cure hair
Group (1): Patients will be treated with Keratin cure ® hair treatment. It will be applied once with use of a flat iron.
Keratin hair treatment (Keratin Cure ®) versus (QOD Max ®)
Hair will be treated with 2 different types of keratin in groups 1 \& 2. All steps of keratin application will be done in group 3 without keratin application as a control group.
Group (2): Treatment with Qod max keratin hair
Group (2): Patients will be treated with QOD Max ® keratin hair treatment. It will be applied once with use of a flat iron.
Keratin hair treatment (Keratin Cure ®) versus (QOD Max ®)
Hair will be treated with 2 different types of keratin in groups 1 \& 2. All steps of keratin application will be done in group 3 without keratin application as a control group.
Group (3): Treatment without keratin hair treatment
Group (3): Patients will be treated without keratin hair treatment, but the same steps of keratin application will be followed.
Keratin hair treatment (Keratin Cure ®) versus (QOD Max ®)
Hair will be treated with 2 different types of keratin in groups 1 \& 2. All steps of keratin application will be done in group 3 without keratin application as a control group.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Keratin hair treatment (Keratin Cure ®) versus (QOD Max ®)
Hair will be treated with 2 different types of keratin in groups 1 \& 2. All steps of keratin application will be done in group 3 without keratin application as a control group.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients having hair loss or under treatment of hair loss in last 3 months.
* Patients with previous history of keratin treatment.
* Patients with scalp affection including infection, injury or surgery
* Patients with chronic medical diseases.
* Patients with anemia (hemoglobin level \<10mg/dl) or under its treatment.
18 Years
55 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sohag University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Amr Abdelhamed
Associate professor, Department of Dermatology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Amr Abdelhamed, MD
Role: PRINCIPAL_INVESTIGATOR
Faculty of Medicine, Sohag University, Egypt
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sohag University
Sohag, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Sohagu310
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.